Moloney Securities Asset Management LLC Sells 5,902 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Moloney Securities Asset Management LLC trimmed its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 16.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 29,318 shares of the company’s stock after selling 5,902 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Roche were worth $1,018,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Saratoga Research & Investment Management raised its stake in shares of Roche by 6.9% during the 1st quarter. Saratoga Research & Investment Management now owns 2,458,918 shares of the company’s stock valued at $78,489,000 after purchasing an additional 158,482 shares during the period. Cardinal Capital Management Inc. bought a new position in Roche in the 2nd quarter worth about $16,860,000. OLD National Bancorp IN increased its stake in Roche by 3.2% in the 2nd quarter. OLD National Bancorp IN now owns 265,242 shares of the company’s stock worth $9,206,000 after acquiring an additional 8,146 shares during the last quarter. Meritage Portfolio Management increased its stake in Roche by 186.9% in the 1st quarter. Meritage Portfolio Management now owns 174,714 shares of the company’s stock worth $5,577,000 after acquiring an additional 113,823 shares during the last quarter. Finally, Associated Banc Corp increased its stake in Roche by 13.8% in the 4th quarter. Associated Banc Corp now owns 48,484 shares of the company’s stock worth $1,761,000 after acquiring an additional 5,890 shares during the last quarter.

Wall Street Analysts Forecast Growth

RHHBY has been the topic of a number of research analyst reports. The Goldman Sachs Group initiated coverage on Roche in a research note on Thursday, May 30th. They issued a “sell” rating on the stock. Deutsche Bank Aktiengesellschaft upgraded Roche from a “sell” rating to a “hold” rating in a research report on Friday, May 17th. Two investment analysts have rated the stock with a sell rating and five have given a hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $40.00.

Roche Stock Performance

OTCMKTS RHHBY opened at $42.33 on Friday. Roche Holding AG has a fifty-two week low of $29.20 and a fifty-two week high of $42.43. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75. The stock has a 50 day simple moving average of $38.40 and a two-hundred day simple moving average of $34.23.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.